We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.59B
AUM Growth
+$232M
Cap. Flow
-$64.7M
Cap. Flow %
-1.41%
Top 10 Hldgs %
19.78%
Holding
784
New
44
Increased
274
Reduced
374
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 21.1%
2 Healthcare 14.9%
3 Industrials 10.39%
4 Financials 9%
5 Communication Services 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGEN
776
DELISTED
HUMANIGEN, INC.
HGEN
-12,500
Closed -$2K
CLVS
777
DELISTED
Clovis Oncology, Inc.
CLVS
-620,203
Closed -$738K
LOTZ
778
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-20,000
Closed -$6K
AERI
779
DELISTED
Aerie Pharmaceuticals
AERI
-964,759
Closed -$14.6M
GBL
780
DELISTED
GAMCO Investors, Inc.
GBL
-48,195
Closed -$822K
IBDN
781
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
-18,400
Closed -$461K
FIEE
782
FiEE Inc
FIEE
$25.9M
-2,600
Closed -$14K

Similar funds

Pinnacle Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Pinnacle Associates held 784 positions worth $4.59B, up 5.3% from $4.36B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q4 2022 filing shows 44 new, 274 increased, 374 reduced and 26 closed positions. Its largest new stake was Canada Goose Holdings: 416,935 shares worth $7.43M. The largest sale was Aerie Pharmaceuticals, an estimated $14.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Pinnacle Associates's largest Q4 2022 buy was Canada Goose Holdings: 416,935 shares worth $7.43M.
  • Pinnacle Associates added most to Illinois Tool Works in Q4 2022, an estimated $7.31M increase.
  • Pinnacle Associates's biggest Q4 2022 reduction was TEGNA Inc, cutting an estimated $12.2M.
  • Pinnacle Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $14.6M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $4.59B portfolio in Q4 2022.
  • Pinnacle Associates opened 44 new positions and closed 26 in Q4 2022.
  • Pinnacle Associates's portfolio value rose 5.3% quarter-over-quarter to $4.59B.

Based on Pinnacle Associates's 13F filing for Q4 2022, filed 25 Jan 2023.